The US Food and Drug Administration (FDA) is seeking input on how to regulate next-generation sequencing (NGS) tests that can scan a tumor's genes to guide cancer treatments. At a public workshop at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results